Stay updated on Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page.
Latest updates to the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has added new features while removing extensive details related to participant groups, interventions, and various data fields available for download.SummaryDifference3%
- Check41 days agoChange DetectedSeveral key health-related resources and clinical trial documents have been removed, including links to MedlinePlus and Dailymed, which may impact access to important medical information.SummaryDifference0.4%
- Check48 days agoChange DetectedThe website has been updated to version v2.12.2, with new additions including links to resources on pancreatic cancer, clinical trials, and various drug information, while the previous version v2.12.1 has been removed.SummaryDifference3%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page.